High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda

PLoS Neglected Tropical Diseases

Volumn 7, Issue 11, 2013, Pages

  Rottbeck, Ruth ^a   Nshimiyimana, Jules Fidèle ^a   Tugirimana, Pierrot ^a   Düll, Uta E ^b   Sattler, Janko ^c   Hategekimana, Jean Claudien ^a   Hitayezu, Janvier ^a   Bruckmaier, Irmengard ^a   Borchert, Matthias ^c   Gahutu, Jean Bosco ^a   Dieckmann, Sebastian ^c   Harms, Gundel ^c   Mockenhaupt, Frank P ^c   Ignatius, Ralf ^c  

^a Butare University Teaching Hospital   (Rwanda)

^b Gikonko Health Center   (Rwanda)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HEAD INJURY; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RWANDA; SCOLEX; TAENIA SOLIUM; CEREBROSPINAL FLUID; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RWANDA; YOUNG ADULT;

EID: 84888249301     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002558     Document Type: Article

References (40)

1. Diop AG, de Boer HM, Mandlhate C, Prilipko L, Meinardi H, (2003) The global campaign against epilepsy in Africa. Acta Trop 87: 149-159.
2. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
3. Sebera F, Balisanga Nyiramazaire H (2006) Prévalence de l'epilepsie au Rwanda: connaissance, perception, vécu et attitudes de la population et des professionnels de la santé. (Prevalence of epilepsy in Rwanda: knowledge, perception, experiences and attitudes of the population and health professionals.). In: Health KMo, editor.
4. Simms V, Atijosan O, Kuper H, Nuhu A, Rischewski D, et al. (2008) Prevalence of epilepsy in Rwanda: a national cross-sectional survey. Trop Med Int Health 13: 1047-1053.
5. Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia 35: 89-93.
6. de Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossio OH, et al. (1996) Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia 37: 1121-1127.
7. de Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossio OH, et al. (1996) Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia 37: 1128-1137.
8. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, (2003) Taenia solium cysticercosis. Lancet 362: 547-556.
9. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, et al. (2011) Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
10. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, et al. (2003) The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 87: 13-23.
11. Mafojane NA, Appleton CC, Krecek RC, Michael LM, Willingham AL 3rd, (2003) The current status of neurocysticercosis in Eastern and Southern Africa. Acta Trop 87: 25-33.
12. Zoli A, Shey-Njila O, Assana E, Nguekam JP, Dorny P, et al. (2003) Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop 87: 35-42.
13. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
14. Del Brutto OH, (2005) Neurocysticercosis. Semin Neurol 25: 243-251.
15. Ito A, Craig PS, (2003) Immunodiagnostic and molecular approaches for the detection of taeniid cestode infections. Trends Parasitol 19: 377-381.
16. Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, et al. (2006) Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. Eur Arch Psychiatry Clin Neurosci 256: 307-310.
17. Michelet L, Fleury A, Sciutto E, Kendjo E, Fragoso G, et al. (2011) Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol 49: 195-200.
18. Yera H, Dupont D, Houze S, Ben M'rad M, Pilleux F, et al. (2011) Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France. J Clin Microbiol 49: 4338-4340.
19. Mayta H, Gilman RH, Prendergast E, Castillo JP, Tinoco YO, et al. (2008) Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol 46: 286-289.
20. Senanayake N, Roman GC, (1993) Epidemiology of epilepsy in developing countries. Bull World Health Organ 71: 247-258.
21. Sander JW, Shorvon SD, (1987) Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry 50: 829-839.
22. Allen AV, Ridley DS, (1970) Further observations on the formol-ether concentration technique for faecal parasites. J Clin Pathol 23: 545-546.
23. Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, et al. (2010) Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 51: 830-837.
24. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, et al. (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
25. Tsang VCW, Wilson M, (1995) Taenia solium Cysticercosis: An Under-recognized but Serious Public Health Problem. Parasitol Today 11: 124-126.
26. Newell E, Vyungimana F, Geerts S, Van Kerckhoven I, Tsang VC, et al. (1997) Prevalence of cysticercosis in epileptics and members of their families in Burundi. Trans R Soc Trop Med Hyg 91: 389-391.
27. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, et al. (2003) Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia 44: 950-955.
28. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2008) Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 102: 1032-1038.
29. Secka A, Grimm F, Victor B, Marcotty T, De Deken R, et al. (2010) Epilepsy is not caused by cysticercosis in The Gambia. Trop Med Int Health 15: 476-479.
30. Proaño-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, Garcia-Jeronimo RC, Correa D, (2002) Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 40: 2115-2118.
31. Matthaiou DK, Panos G, Adamidi ES, Falagas ME, (2008) Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis 2: e194.
32. Takayanagui OM, Odashima NS, (2006) Clinical aspects of neurocysticercosis. Parasitol Int 55 Suppl: S111-115.
33. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, et al. (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 1007-1009.
34. Foyaca-Sibat H, Cowan LD, Carabin H, Targonska I, Anwary MA, et al. (2009) Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. PLoS Negl Trop Dis 3: e562.
35. Gabriel S, Blocher J, Dorny P, Abatih EN, Schmutzhard E, et al. (2012) Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis 6: e1851.
36. Enk MJ, Lima AC, Drummond SC, Schall VT, Coelho PM, (2008) The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission. Acta Trop 108: 222-228.
37. Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VC, et al. (2009) Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis 3: e371.
38. Bethony JM, Cole RN, Guo X, Kamhawi S, Lightowlers MW, et al. (2011) Vaccines to combat the neglected tropical diseases. Immunol Rev 239: 237-270.
39. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, et al. (2010) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40: 515-519.
40. Praet N, Speybroeck N, Manzanedo R, Berkvens D, Nsame Nforninwe D, et al. (2009) The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl Trop Dis 3: e406.